Comparison of healthcare resource utilization and costs in patients hospitalized for acute coronary syndrome managed with percutaneous coronary intervention and receiving prasugrel or ticagrelor

References

• Jneid H, Anderson JL, Wright RS, et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non–ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2012;60:654-90
   Web of Science ®Google Scholar
• O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;127:e362-425
   PubMed Web of Science ®Google Scholar
• Wiviott SD, Braunwald E, McCabe CH, et al; TRITON-TIMI 38 (Investigators). Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-15
   PubMed Web of Science ®Google Scholar
• Wallentin L, Becker RC, Budaj A. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045-57
   PubMed Web of Science ®Google Scholar
• Effient [package insert]. Indianapolis, IN: Eli Lilly and Company, 2013
   Google Scholar
• Malenka DJ, Kaplan AV, Sharp SM, et al. Postmarketing surveillance of medical devices using Medicare claims. Health Affairs 2005;24:928-37
   Web of Science ®Google Scholar
• National Quality Measures Clearinghouse. Acute myocardial infarction: hospital 30-day, all cause, risk-standardized readmission rate (RSMR) following AMI hospitalization. Rockville, MD: Agency for Healthcare Research and Quality (AHRQ), 2014. Available at: http://www.qualitymeasures.ahrq.gov/content.aspx?id=46498 [Last accessed 6 January 2015]
   Google Scholar
• Joynt KE, Jha AK. A Path Forward on Medicare Readmissions. New Engl J Med 2013;368:1175-7
   PubMed Web of Science ®Google Scholar
• Rau J. Armed with bigger fines, Medicare to punish 2,225 hospitals for excess readmissions. Washington, DC: Kaiser Health News, 2013. Available at: http://kaiserhealthnews.org/news/readmission-penalties-medicare-hospitals-year-two/ [Last accessed 6 January 2015]
   Google Scholar
• Chastek B, Riedel AA, Wygant G, et al. Evaluation of hospitalization and follow-up costs among patients hospitalized with ACS treated with a stent and clopidogrel. Curr Med Res Opin 2009;25:2845-52
   PubMed Web of Science ®Google Scholar
• Meadows E, Bae J, Zagar A, et al. Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis. BMC Res Notes 2012;5:342
   PubMedGoogle Scholar
• Curtis JP, Schreiner G, Wang Y, et al. All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of Medicare patients. J Am Coll Cardiol 2009;54:903-7
   PubMed Web of Science ®Google Scholar
• Biondi-Zoccai G, Lotrionte M, Agostoni P, et al. Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes. Int J Cardiol 2011;150:325-31
   PubMed Web of Science ®Google Scholar
• Steiner S, Moertl D, Chen L, et al. Network meta-analysis of prasugrel, ticagrelor, high- and standard-dose clopidogrel in patients scheduled for percutaneous coronary interventions. Thromb Haemost 2012;108:318-27
   PubMed Web of Science ®Google Scholar
• Deharo P, Bassez C, Bonnet G, et al. Prasugrel versus ticagrelor in acute coronary syndrome: a randomized comparison. Int J Cardiol 2013;170:e21-2
   PubMed Web of Science ®Google Scholar
• Alexopoulos D, Stavrou K, Koniari I, et al. Ticagrelor vs prasugrel one-month maintenance therapy: impact on platelet reactivity and bleeding events. Thromb Haemost. 2014;112:551-7
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Ghose A, Sharma A, et al. Comparing newer oral anti-platelets prasugrel and ticagrelor in reduction of ischemic events-evidence from a network meta-analysis. J Thromb Thrombolysis 2013;36:223-32
   PubMed Web of Science ®Google Scholar
• Passaro D, Fadda V, Maratea D, et al. Anti-platelet treatments in acute coronary syndrome: simplified network meta-analysis. Int J Cardiol 2011;150:364-7
   PubMed Web of Science ®Google Scholar
• Zhao Z, Winget M. Economic burden of illness of acute coronary syndromes: medical and productivity costs. BMC Health Serv Res 2011;11:35
   PubMed Web of Science ®Google Scholar
• Etemad LR, McCollam PL. Total first-year costs of acute coronary syndrome in a managed care setting. J Manag Care Pharm 2005;11:300-6
   PubMedGoogle Scholar
• Scirica BM, Cannon CP, Emanuelsson H, et al. The Incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) Trial: results of the Continuous Electrocardiographic Assessment Substudy. J Am Coll Cardiol 2011;57:1908-16
   PubMed Web of Science ®Google Scholar
• Bonello L, Laine M, Kipson N, et al. Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome. J Am Coll Cardiol 2014;63:872-7
   PubMed Web of Science ®Google Scholar
• Bonafede M, Jing Y, Gdovin Bergeson J, et al. Impact of dyspnea on medical utilization and affiliated costs in patients with acute coronary syndrome. Hosp Pract 2011;39:16-22
   PubMedGoogle Scholar
• Belchikov YG, Koenig SJ, Dipasquale EM. Potential role of endogenous adenosine in ticagrelor-induced dyspnea. Pharmacotherapy 2013;33:882-7
   PubMed Web of Science ®Google Scholar
• Saini SD, Schoenfeld P, Kaulback K, et al. Effect of medication dosing frequency on adherence in chronic diseases. Am J Manag Care 2009;15:e22-33
   PubMed Web of Science ®Google Scholar
• McCollam P, Etemad L. Cost of care for new-onset acute coronary syndrome patients who undergo coronary revascularization. J Invasive Cardiol 2005;17:307-11
   PubMedGoogle Scholar
• Menzin J, Wygant G, Hauch O, et al. One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multiemployer claims database. Curr Med Res Opin 2008;24:461-8
   PubMed Web of Science ®Google Scholar
• Ducrocq G, Amarenco P, Labreuche J, et al. A history of stroke/transient ischemic attack indicates high risks of cardiovascular event and hemorrhagic stroke in patients with coronary artery disease. Circulation 2013;127:730-8
   PubMed Web of Science ®Google Scholar
• Berenson K, Ogbonnaya A, Casciano R, et al. Economic consequences of ACS-related rehospitalizations in the US. Curr Med Res Opin 2010;26:329-36
   PubMed Web of Science ®Google Scholar